Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.3

-0.26

-0.23

-0.19

Details

Expected EPS

-0.243979

Actual EPS

-0.27

Surprise EPS

-0.03

Surprise Percent

+10.67%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.27 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.